CRIA clinical trials.
D000225:Adenine / Q000627:therapeutic use / Q000031:analogs & derivatives; D000480:Alkynes; D045930:Anabolic Agents / Q000008:administration & dosage; D019380:Anti-HIV Agents / Q000627:therapeutic use; D048588:Benzoxazines; D001786:Blood Glucose; D002986:Clinical Trials as Topic; D003521:Cyclopropanes; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D063065:Organophosphonates; D010074:Oxandrolone / Q000008:administration & dosage; D010078:Oxazines / Q000627:therapeutic use; D018579:Patient Selection; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D015431:Weight Loss
D000480:Alkynes; D045930:Anabolic Agents; D019380:Anti-HIV Agents; D048588:Benzoxazines; D001786:Blood Glucose; D003521:Cyclopropanes; D017320:HIV Protease Inhibitors; D063065:Organophosphonates; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D019469:Indinavir; D010074:Oxandrolone; D000225:Adenine; C098320:efavirenz; C106812:adefovir dipivoxil